Blood and neoplastic diseases. Myeloproliferative disorders.
نویسندگان
چکیده
منابع مشابه
Myeloproliferative disorders and its associated mutations
Myeloproliferative Neoplasm (MPN) are a clonal disorder in hematopoietic stem cells (HSC). MPN is categorized to 8 subclasses, including chronic myeloid leukemia (CML), polycythemia vera (PV), essential thrombocytopenia (ET), primary myelofibrosis (PMF), systematic mastositosis (SM), chronic eosinophilic leukemia (CEL), chronic neutrophilic leukemia (CNL), and unclassified myelofibrosis disorde...
متن کاملBlood pyruvate in malignant neoplastic disorders.
A moderate and statistically significant elevation of blood pyruvate levels, determined by an enzymatic method, was found in 60 patients with various malignant neoplastic disorders as compared with 20 control subjects. Studied were 42 cases of metastatic carcinoma, including 14 in which there were hepatic metastases and 18 cases of leukemia and lymphoma. No significant statistical difference wa...
متن کاملBlood and neoplastic diseases. Treatment of the lymphomas.
The term lymphoma is used to describe those primary malignant diseases of lymphoreticular tissue which usually arise in lymph nodes, the diagnosis being made by microscopic examination of biopsy material. The precise histological type is important and a simple classification on which treatment is based is shown in table I. Several diseases have been omitted, such as macroglobu-linaemia, because...
متن کاملChronic Myeloproliferative Disorders
JAK2, an acquired mutation of JAK2, is present in a majority of patients with polycythemia vera and to a lesser extent among patients with the other myeloproliferative disorders. We analyzed the effect of JAK2 on the expression of polycythemia rubra vera 1(PRV-1), using an in vitro model. Compared to wild-type JAK2, the presence of JAK2 increased both PRV-1 protein and mRNA levels in murine mye...
متن کاملEosinophilic myeloproliferative disorders.
Despite recent attempts to define and classify patients with marked eosinophilia and features consistent with myeloproliferative disease, areas of controversy remain. These are particularly apparent in situations in which multiple lineages are involved in a clonal process and clinical manifestations are overlapping. Although the introduction of new molecular diagnostics and targeted therapies h...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMJ
سال: 1974
ISSN: 0959-8138,1468-5833
DOI: 10.1136/bmj.4.5941.399